Inventor · disambiguated record
William Winston
Also filed as: WINSTON SR WILLIAM M · WINSTON WILLIAM · WINSTON WILLIAM M
18 granted patents·22 pending applications·107 citations·filing 2002–2025
93Inventor score
Files withWEREWOLF THERAPEUTICS INC23POTENZA THERAPEUTICS INC9TRIEZA THERAPEUTICS INC4HARVARD COLLEGE2UNIV TEXAS1
Top patents by PatentIndex Score
40 records- 0196US11352403B2Activatable interleukin-2 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Granted Jun 7, 2022·6 cites·13 claims
- 0296US10696724B2Activatable interleukin-2 polypeptidesWEREWOLF THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·18 cites·11 claims
- 0395US10696723B2Activatable interleukin 12 polypeptidesWEREWOLF THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·15 cites·12 claims
- 0494US11535658B2Activatable interleukin-2 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2021·Granted Dec 27, 2022·2 cites·21 claims
- 0594US9713641B2Anti-TIGIT antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2017·Granted Jul 25, 2017·35 cites·20 claims
- 0693US11981716B2Activatable interleukin-2 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2021·Granted May 14, 2024·2 cites·13 claims
- 0791US10232053B2Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancerTRIEZA THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·23 cites·5 claims
- 0883US10227413B2Anti-neuropilin antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·2 cites·20 claims
- 0982US10507244B2Anti-TIGIT antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2017·Granted Dec 17, 2019·3 cites·24 claims
- 1082US2024358796A1Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1181US11186644B2Anti-neuropilin antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2019·Granted Nov 30, 2021·1 cites·11 claims
- 1279US12076371B2Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2023·Granted Sep 3, 2024·0 cites·29 claims
- 1378US12275769B2Activatable interleukin 12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Granted Apr 15, 2025·0 cites·14 claims
- 1478US12036266B2Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Granted Jul 16, 2024·0 cites·19 claims
- 1578US2024262880A1Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1675US11739132B2Separation moieties and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·0 cites·16 claims
- 1775US2024174725A1Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1874US2025179138A1Activatable interleukin 12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1974US2023272028A1Separation moieties and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2074US2023051423A1Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2170US11453710B2Activatable interleukin 12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·0 cites·16 claims
- 2268US2022098312A1Anti-neuropilin antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2368US2021393803A1Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancerTRIEZA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2465US2024216470A1Inducible il-2 and pd-1/pd-l1 combination therapyWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2565US2024216505A1Inducible cytokine prodrug and pd-1/pd-l1 combination therapyWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2665US2024216474A1Activatable interferon polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2764US2021130430A1Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2862US2021115102A1Separation moieties and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2961US11590224B2Anti-TIGIT antigen-binding proteins and methods of uses thereofPOTENZA THERAPEUTICS INC·Filed 2019·Granted Feb 28, 2023·0 cites·8 claims
- 3061US2020014798A1Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancerTRIEZA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3160US2024043488A1Activatable il-12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3259US2024374687A1Il-2 prodrugWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3358US2021269542A1Anti-gitr antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3452US10988545B2Anti-GITR antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2018·Granted Apr 27, 2021·0 cites·11 claims
- 3552US2009077679A1Gene silencing by systemic rna interferenceHARVARD COLLEGE·Filed 2008·Application pending·0 cites
- 3652US2023128075A1Monoclonal antibodies targeting hsp70 and therapeutic uses thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 3752US2019142967A1Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Production and Use Thereof for Treatment of CancerTRIEZA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3848US2003167490A1Gene silencing by systemic RNA interferenceFiled 2002·Application pending·0 cites
- 3946US2007191295A1Gene silencing by systemic rna interferenceHARVARD COLLEGE·Filed 2004·Application pending·0 cites
- 4040US11453720B2Anti-TIGIT antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2018·Granted Sep 27, 2022·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when William Winston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →